Roundtable Talk
Biosimulation for Accelerating Drug Development in Immuno-Oncology
| Piet van der Graaf, SVP Quantitative Science Services, Rik de Greef, Senior Vice President - Global Lead Quantitative Science Service iDD
A rapidly developing area within Complex Biologics is Immuno-Oncology(IO), where biosimulations have become integral in creating a path between clinical phases. This newly recognized method of cancer treatment can provide unique challenges in translational science, clinical development and navigating regulatory pathways. Certara will discuss how a disciplined and proven clinical pharmacology strategy, coupled with in silico modeling and simulation will maximize program efficiency and increase the likelihood of an IO program’s success.
Powered by Translations.com GlobalLink OneLink Software